Clinical Trial: Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281378) titled 'Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.' on Dec. 11.

Brief Summary: This intervention will focus on stimulant-using men at high risk for HIV who are in need of tailored behavioral interventions to mitigate co-occurring stimulant use and HIV risk in the era of pre-exposure prophylaxis (PrEP). The study is a pilot randomized controlled trial to evaluate the adaptation, feasibility, acceptability, and preliminary efficacy of a behavioral intervention.

Study Start Date: Jan. 01, 2026

Study Type: INTERVENTIONAL

Condition: Drug Use Disorders PrEP ...